Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_3
3
43%
Ph phase_4
1
14%
Ph not_applicable
1
14%
Ph phase_2
2
29%

Phase Distribution

0

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
3(42.9%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (28.6%)
Phase 33 (42.9%)
Phase 41 (14.3%)
N/A1 (14.3%)

Trials by Status

unknown114%
withdrawn114%
completed571%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_3

Iron Babies Pilot Supplementation Trial

NCT04751994
completedphase_3

Safety and Efficacy of Sublingual Immunotherapy for Allergic Rhinitis Due to Artemisia Annua

NCT03990272
completedphase_3

Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis

NCT03649139
completedphase_2

A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen

NCT00291642
completedphase_2

Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy

NCT01449786
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT04751994Phase 3

Iron Babies Pilot Supplementation Trial

Completed
NCT03990272Phase 3

Safety and Efficacy of Sublingual Immunotherapy for Allergic Rhinitis Due to Artemisia Annua

Completed
NCT03649139Phase 3

Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis

Completed
NCT00291642Phase 2

A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen

Completed
NCT01449786Phase 2

Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy

Completed
NCT01284907Not Applicable

Vit D to Treat Asthma in Children: a Randomized, Double-blind, Placebo-controlled Trial

Withdrawn
NCT01386736Phase 4

Vitamin D and Glucose Metabolism in Pediatrics

Unknown

All 7 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
7